New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India

Archives of Virology

Volumn 157, Issue 11, 2012, Pages 2083-2093

  Medhi, Subhash ^a,g   Goswami, Bhabadev ^b   Das, Anup K ^c   Singh, Thongam Bhimo ^d   Husain, Syed Akhtar ^e   Sehgal, Ashok ^f   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

^c ASSAM MEDICAL COLLEGE   (India)

^d REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

^e JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^f INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^g GAUHATI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD; CLASSIFICATION; DNA SEQUENCE; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INDIA; ISOLATION AND PURIFICATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEX DIFFERENCE; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INDIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84868489375     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1374-z     Document Type: Article

References (62)

1. Kuo G, Choo QL, Alter HJ et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
2. NIH Consensus Statement on Management of Hepatitis C (2002) NIH Consensus State Sci Statements 19(3): 1-46.
3. Leone N, Rizzetto M (2005) Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 51(1): 31-46.
4. Charlton M (2001) Hepatitis C infection in liver transplantation. Am J Transplant 1(3): 197-203.
5. Poovorawan Y, Chatchatee P, Chongsrisawat V (2002) Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol 17(Suppl): S155-S166.
6. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78: 321-328.
7. Okamoto H, Kojima M, Okada S et al (1992) Genetic drift of hepatitis C virus during an 8. 2-year infection in a chimpanzee: variability and stability. Virology 190: 894-899.
8. Mizokami M, Gojobori T, Lau JYN (1994) Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology 107: 1181-1182.
9. Simmonds P (1995) Variability of hepatitis C virus. Hepatology 21: 570-583.
10. Bukh J, Purcell RH, Miller RH (1994) Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 91: 8239-8243.
11. Simmonds P, Holmes EC, Cha TA et al (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74: 2391-2399.
12. Maertens G, Stuyver L (1997) Genotypes and genetic variation of hepatitis. In: Harrison TJ, Zuckerman A (eds) The molecular medicine of viral hepatitis. Wiley, Chichester, pp 183-233.
13. Chamberlain RW, Adams N, Saeed AA et al (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78: 1341-1347.
14. Chamberlain RW, Adams NJ, Taylor LA et al (1997) The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236: 44-49.
15. Amarapurkar D, Dhorda M, Kirpalani A et al (2001) Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 49: 983-985.
16. Panigrahi AK, Roca J, Acharya SK et al (1996) Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 48: 191-198.
17. Raghuraman S, Shaji RV, Sridharan G et al (2003) Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 26(1): 61-69.
18. Hazari S, Panda SK, Gupta SD et al (2004) Treatment of hepatitis C virus infection in patients of northern India. J Gastroenterol Hepatol 19(9): 1058-1065.
19. Chowdhury A, Santra A, Chaudhuri S et al (2003) Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 37(4): 802-809.
20. Hissar SS, Goyal A, Kumar M et al (2006) Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 78(4): 452-458.
21. Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrison TJ (1995) Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 76: 711-716.
22. Chandra M, Thippavuzzula R, Ramachandra Rao VV (2007) Genotyping of hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol 7(6): 724-730.
23. Mori S, Kato N, Yagyu A et al (1992) A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 183: 334-342.
24. Tokita H, Okamoto H, Tsuda F et al (1994) Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 91: 11022-11026.
25. Hotta H, Handajani R, Lusida MI et al (1994) Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences. J Clin Microbiol 32: 3049-3051.
26. Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37(5): 337-345.
27. Simmonds P (2000) HCV Genotypes. In: Liang J, Hoofnagle JH (eds) Hepatitis C-biomedical research reports. Academic Press, USA, pp 53-70.
28. Zein NN (2000) Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13: 223-235.
29. Smith DB, Mellor J, Jarvis LM, The International HCV Collaborative Study Group et al (1995) Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 6: 1749-1761.
30. Ghany MG, Strader DB, Thomas DL, American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4): 1335-1374.
31. Chinchai T, Labout J, Noppornpanth S et al (2003) Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 109: 195-201.
32. Cantaloube J-F, Gallian P, Attoui H et al (2005) Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from Southeast France. J Clin Microbiol 43: 3624-3629.
33. Simmonds P, Bukh J, Combet C et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4): 962-973.
34. Morice Y, Roulot D, Grando V et al (2001) Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82(5): 1001-1012.
35. Soni PN, Tait DR, Gopaul W et al (1996) Hepatitis C virus infection in chronic liver disease in Natal. S Afr Med J 86(1): 80-83.
36. Ayoola EA, al-Mofleh IA, al-Faleh FZ et al (1992) Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases. Hepatogastroenterology 39(4): 337-339.
37. Kim BS, Park YM (1993) Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterol Jpn. 28(Suppl 5): 17-22.
38. Sulaiman HA, Noer HM, Endardjo S, Hoyaranda E (1991) The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia. Gastroenterol Jpn 26(Suppl 3): 179-183.
39. Irshad M, Acharya SK (1994) Status of hepatitis viral markers in patients with acute and chronic liver diseases in northern India. Intervirology 37(6): 369-372.
40. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINVIR and DOSVIRC groups. Lancet 349: 825-832.
41. Ramesh R, Munshi A, Panda SK (1992) Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 7(4): 393-395.
42. Nguyen MH, Keeffee EB (2005) Chronic hepatitis: genotypes 4 to 9. Clin Liver Dis 9: 411-426.
43. Hayashi K, Fukuda Y, Nakano I, Katano Y, Yoyoda H, Yokozaki S, Hayakawa T, Morita K, Nishimura D, Kato K, Urano T, Takamatsu K (2003) Prevalence and characterization of hepatitis C virus genotyping Japanese hepatitis carriers. Hepatol Res 25: 409-414.
44. Das BR, Kundu B, Khandapkar R, Sahni S (2002) Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 45: 323-328.
45. Raghuraman S, Abraham P, Sridharan G et al (2004) HCV genotype 4-an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 31(4): 253-258.
46. Echevarria JM, Leon P, Pozo F, Avellon A (2006) Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infect Microbiol Clin 24: 20-25.
47. Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A (2006) Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13: 19-27.
48. Savvas SP, Koskinas J, Sinanai C, Hadziyannis A, Spanou F, Hadziyannis SJ (2005) Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12: 551-557.
49. Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37: 337-345.
50. Shinji T, Kyaw YY, Gokan K, Tanaka Y, Ochi K, Kusano N, Mizushima T, Fujioka S, Shiraha H, Lwin AA, Shiratori Y, Mizokami M, Khin M, Miyahara M, Okada S, Koide N (2004) Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. Acta Med Okayama 58(3): 135-142.
51. Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83: 1071-1078.
52. Nguyen NH, Vutien P, Garcia RT et al (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17: 691-697.
53. Vutien P, Nguyen NH, Trinh HN et al (2010) Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. Am J Gastroenterol 105: 1110-1115.
54. Mellor J, Walsh EA, Prescott LE, Jarvis LM, Davidson F, Yap PL, Simmonds P (1996) Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 34(2): 417-423.
55. Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H (1996) Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34(3): 569-574.
56. Zylberberg H, Chaix ML, Brechot C (2000) Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Letter. Ann Intern Med 132: 845-846.
57. Khan MH, Farrell GC, Byth K et al (2000) Which patients with hepatitis C develop liver complications? Hepatology 31: 513-520.
58. He Y, Zhang J, Zhong L, Chen X, Liu HM, Wan LK, Wang H, Li H, Tian L, Hu JL, Luo P, Wang L, Chen Y, Liu T, Liu SL, Lü WB (2011) Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu. China J Med Virol 83(4): 616-621.
59. van Asten L, Verhaest I, Lamzira S et al (2004) European and Italian Seroconverter Studies. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189(2): 292-302.
60. McHutchison JG, Manns M, Patel K, International Hepatitis Interventional Therapy Group et al (2002) Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123(4): 1061-1069.
61. De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Gastroenterology Association of Puerto Rico et al (2008) Sexual activity as a risk factor for hepatitis C in Puerto Rico. Bol Asoc Med P R 100(3): 15-20.
62. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol 45(4): 1102-1112.